Biopharma Advised to Beat the Clock on Patent Reform

If biopharma companies heed the advice of their patent attorneys, there will be a mad dash to the Patent and Trademark Office (PTO) over the next few weeks as firms rush to file new patents before the reforms of the America Invents Act (AIA) take effect March 16.